While not officially in recession, the U.S. economy grew by less than one percent in the first half of 2011, with nearly 25 million Americans either out of work or working part-time (1). It is difficult to find an industry sector that has not been affected by these challenging economic conditions.
Despite the difficult economic climate, Viscira, a leading provider of interactive, new-media and technology solutions for the life sciences industry, continues to enjoy success. In fact, the company estimates that its gross revenue for FY 2011 will increase by more than 50 percent from the prior fiscal year.
During 2011, Viscira added several major new clients including Bristol-Myers Squibb, Celgene, MedImmune, Teva, Lundbeck, and Seattle Genetics to its roster of prominent life science customers. The company also continues to expand its volume of business with existing clients such as Genentech/Roche, Johnson & Johnson, Abbott Labs and Novartis.
In order to accommodate the greater business volume, the company meaningfully increased its full-time staffing levels over this same period. It also expanded its office space in both San Francisco and New York City.
“We are very pleased to have achieved these results over the past year,” explains Dave Gulezian, President & CEO of Viscira. “I think it is a real testament to the talent, hard work and dedication of the exceptional people we have on our team. It is gratifying to see that our clients continue to be excited by the innovative technology solutions we are delivering.”
Viscira’s growth has been driven by increasing demand across the company’s portfolio of interactive products and technology platforms from next-generation, 3D mechanism of action animations to enhanced KOL video presentation modules to its robust online Interactive Presentation Builder (IPB) system. Viscira also expects demand for the company’s distinctive iPad applications for the industry to continue to rise significantly in 2012.
(1)CBS Money Watch, Are We Headed for Another Recession? 8/19/11.